Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma. (Q37911948)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 05 August 2011

Language	Label	Description	Also known as
English	Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma.	scientific article published on 05 August 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

Europe PubMed Central

Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

0 references

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Lisa M DeAngelis

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

M Deckert

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

A Engert

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

W Brück

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

A J M Ferreri

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

J Finke

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

G Illerhaus

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

W Klapper

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

A Korfel

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

M Maarouf

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

M Montesinos-Rongen

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

W Paulus

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

U Schlegel

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

O D Wiestler

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

R Siebert

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

5 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1797-1807

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818113%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Intraocular lymphoma 2000-2005: results of a retrospective multicentre trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Meningeal dissemination in primary CNS lymphoma: prospective evaluation of 282 patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Primary leptomeningeal lymphoma: report of 9 cases, diagnosis with immunocytochemical analysis, and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Apoptosis and apoptosis-related gene products in primary non-Hodgkin's lymphoma of the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

[Follicular and mantle cell lymphoma. Extranodal involvement of primarily nodal indolent B-cell lymphomas].

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

AIDS-related non-Hodgkin's lymphoma in the first decade of highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Primary central nervous system lymphoma in a patient treated with natalizumab

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Primary cerebral lymphomatoid granulomatosis: report of four cases and literature review

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Neuropathology of CNS disease in Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Diagnosis of inflammatory demyelination in biopsy specimens: a practical approach

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Interphase cytogenetic analysis of lymphoma-associated chromosomal breakpoints in primary diffuse large B-cell lymphomas of the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Mutations of CARD11 but not TNFAIP3 may activate the NF-kappaB pathway in primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Frequent inactivation of A20 in B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Gene expression and angiotropism in primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Pathway analysis of primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Array-based DNA methylation profiling of primary lymphomas of the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Lymphoma stem cells: enough evidence to support their existence?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

From brain to testis: immune escape and clonal selection in a B cell lymphoma with selective outgrowth in two immune sanctuaries [correction of sanctuariesy].

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Clonal evolution as pathogenetic mechanism in relapse of primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Detection of subclinical systemic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Molecular footprints of a germinal center derivation of human IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Comparison of integrin adhesion molecules expressed by primary brain lymphomas and nodal lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Toxoplasma encephalitis of immunocompetent and nude mice: immunohistochemical characterisation of Toxoplasma antigen, infiltrates and major histocompatibility complex gene products

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Short intensive primary chemotherapy and radiotherapy in sporadic primary CNS lymphoma (PCL).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

A multicenter study of treatment of primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Successful treatment of non-Hodgkin's lymphoma of the central nervous system with BMPD chemotherapy followed by radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Combined-modality therapy for primary central nervous system lymphoma: long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Primary central nervous system lymphoma can be histologically diagnosed after previous corticosteroid use: a pilot study to determine whether corticosteroids prevent the diagnosis of primary central nervous system lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Results of radiation monotherapy for primary central nervous system lymphoma in the 1990s

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Therapy of primary central nervous system lymphoma with pre-irradiation methotrexate, cyclophosphamide, doxorubicin, vincristine, and dexamethasone (MCHOD).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

A comparative study on the pharmacokinetics of methotrexate in a dose range of 0.5 g to 33.6 g/m2 in children with acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Glucocorticoid treatment of primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Temozolomide as salvage treatment in primary brain lymphomas.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Prospective trial on topotecan salvage therapy in primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Delayed neurotoxicity in primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

21 January 2018

Primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical removal of primary central nervous system lymphomas (PCNSL) presenting as space occupying lesions: a series of 33 cases

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary low-grade B-cell lymphoma of the dura: a mucosa associated lymphoid tissue-type lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Central nervous system vasculitis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Recurrent Inactivation of the PRDM1 Gene in Primary Central Nervous System Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Transcriptional Profiling of the Nuclear Factor-κB Pathway Identifies a Subgroup of Primary Lymphoma of the Central Nervous System With Low BCL10 Expression

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Epigenetic silencing of multiple genes in primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term survival in primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment for primary CNS lymphoma: the next step

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: response to therapy and quality of life of patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37911948&oldid=2201073987"